Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients

類似資料

• Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2
  著者:: Jiang, Shibo, 等
  出版事項: (2020)
• SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies
  著者:: Yang, Yang, 等
  出版事項: (2021)
• Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine
  著者:: He, Yuxian, 等
  出版事項: (2004)
• Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity
  著者:: Du, Lanying, 等
  出版事項: (2009)
• Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC
  著者:: Du, Lanying, 等
  出版事項: (2013)